Abstract: The increasing adoption of Industrial Internet of Things (IIoT) networks has introduced new security challenges, particularly to ensure software security against evolving malware threats.

The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.